表紙：バイオディフェンスの市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測 2025-2032年

市場調査レポート

商品コード

1724868

バイオディフェンスの市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測 2025-2032年

Biodefense Market Size, Share, and Growth Analysis, By Product (Vaccines, Biothreat Detection Devices), By Application (Military, Civilian), By End User, By Region - Industry Forecast 2025-2032

出版日: 2025年05月08日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 768,023円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 898,442円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,028,861円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.91円

全表示
概要
目次

概要

サンプル依頼リストに入れる

バイオディフェンスの世界市場規模は2023年に144億米ドルと評価され、2024年の152億9,000万米ドルから2032年には247億4,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは6.2％で成長する見通しです。

バイオディフェンス市場の成長は、政府の強力なイニシアチブ、民間投資の活発化、インフルエンザ、ジカ熱、エボラ出血熱などの流行に対応したバイオディフェンス戦略に焦点を当てた支出の増加によって促進されています。遺伝子工学やバイオテクノロジーにおける最近の技術進歩は、致死性のウイルスの改変を可能にし、潜在的な生物兵器の脅威に対する懸念を高めています。炭疽菌やボツリヌス菌など、過去にバイオテロに使用されたことのあるさまざまな生物学的製剤により、世界各国の政府は、生物学的脅威と闘い、リスクを最小限に抑えるために、厳格な対策、条約、政策を採用しています。国立感染症研究所は、2001年の炭疽菌テロ以来、感染症の研究において重要な役割を果たし、バイオテロに対処するための医療品や戦略の開発に貢献しており、世界の健康安全保障における市場の重要性を強調しています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2024年）
主な市場企業が採用した戦略
最近の市場動向
企業の市場シェア分析（2024年）
主要企業の企業プロファイル
- 企業の詳細
- 製品ポートフォリオ分析
- 企業のセグメント別シェア分析
- 収益の前年比比較（2022-2024年）

主要企業プロファイル

Emergent BioSolutions Inc.（United States）
SIGA Technologies, Inc.（United States）
Dynavax Technologies Corporation（United States）
Altimmune Inc.（United States）
XOMA Corporation（United States）
Cleveland BioLabs Inc.（United States）
Ichor Medical Systems, Inc.（United States）
ANP Technologies, Inc.（United States）
PositiveID Corporation（United States）
Alexeter Technologies LLC（United States）
BioFire Defense（bioMerieux SA）（United States）
Elusys Therapeutics Inc.（United States）
Battelle National Biodefense Institute, LLC（United States）
Gryphon Scientific LLC（United States）
BioRisk Reduction（United States）
CBRNe Science and Consequence Management World Congress（United States）
Mammoth Biosciences（United States）
Alnylam Pharmaceuticals Inc.（United States）
Bruker Detection（United States）
New Horizon Diagnostic Corp.（United States）

結論と提言

Product Code: SQMIG35H2213

Global Biodefense Market size was valued at USD 14.4 billion in 2023 and is poised to grow from USD 15.29 billion in 2024 to USD 24.74 billion by 2032, growing at a CAGR of 6.2% during the forecast period (2025-2032).

The growth of the biodefense market is fueled by robust government initiatives, heightened private investments, and increased spending focused on biodefense strategies in response to outbreaks like flu, Zika, and Ebola. Recent technological advancements in genetic engineering and biotechnology enable the modification of deadly viruses, raising concerns about potential bioweapon threats. With various biological agents previously used in bioterrorism-such as anthrax and botulism-governments worldwide are adopting stringent biodefense measures, treaties, and policies to combat biological threats and minimize risks. The National Institute of Infectious Disease plays a crucial role in researching infectious diseases, contributing to the development of medical products and strategies to tackle bioterrorism since the 2001 anthrax attacks, underscoring the market's significance in global health security.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biodefense market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biodefense Market Segments Analysis

Global Biodefense Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Vaccines and Biothreat Detection Devices. Based on Application, the market is segmented into Military and Civilian. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biodefense Market

The Global Biodefense market is significantly driven by substantial investments from federal and state governments aimed at enhancing national and public health security. These expenditures are essential for the development of vaccines, diagnostics, and treatments that ensure healthcare systems are well-prepared for potential biological threats. Furthermore, governments are channeling funds into emergency planning, infrastructure, and training, creating an environment conducive to the advancement of innovative biodefense strategies. This proactive approach not only bolsters preparedness against biological attacks but also strengthens resilience in the face of pandemics, thereby significantly influencing market growth and development.

Restraints in the Global Biodefense Market

The global biodefense market faces significant challenges due to intense competition among established companies, which can result in price wars and diminished profit margins. This competitive landscape poses barriers for new entrants seeking to penetrate the market. Larger enterprises typically wield considerable resources and maintain established connections with regulatory authorities, allowing them to exert substantial influence. To safeguard their market share, these dominant firms may adopt aggressive pricing strategies that not only compress profits but also stifle the growth potential of smaller companies. Consequently, this dynamic creates a challenging environment for emerging players in the vital biodefense sector.

Market Trends of the Global Biodefense Market

The Global Biodefense market is increasingly influenced by the rising trend of personalized medicine, which focuses on developing customized vaccines and treatments tailored to specific demographics and biological threats. This innovative approach enhances response mechanisms to infectious diseases, allowing for more effective public health strategies. As advancements in genomics and biotechnology progress, researchers anticipate the creation of highly effective vaccines designed to align with the unique genetic profiles of diverse populations. Consequently, this trend not only promises to improve individual health outcomes but also strengthens national biodefense strategies by enabling targeted and efficient responses to emerging infectious threats.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technology Analysis

Global Biodefense Market Size by Product & CAGR (2025-2032)

Market Overview
Vaccines
- Anthrax
- Smallpox
- Botulism
- Others
Biothreat Detection Devices
- Samplers
- Detectors/Triggering Devices
- Identifiers
- Assays and Reagents

Global Biodefense Market Size by Application & CAGR (2025-2032)

Market Overview
Military
Civilian

Global Biodefense Market Size by End User & CAGR (2025-2032)

Market Overview
Hospitals & Clinics
Ambulatory Care Centers
Others

Global Biodefense Market Size & CAGR (2025-2032)

North America (Product, Application, End User)
- US
- Canada
Europe (Product, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Emergent BioSolutions Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SIGA Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dynavax Technologies Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Altimmune Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
XOMA Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cleveland BioLabs Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ichor Medical Systems, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ANP Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PositiveID Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alexeter Technologies LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioFire Defense (bioMerieux SA) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elusys Therapeutics Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Battelle National Biodefense Institute, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gryphon Scientific LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioRisk Reduction (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CBRNe Science and Consequence Management World Congress (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mammoth Biosciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alnylam Pharmaceuticals Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Detection (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New Horizon Diagnostic Corp. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

バイオディフェンスの市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測 2025-2032年

Biodefense Market Size, Share, and Growth Analysis, By Product (Vaccines, Biothreat Detection Devices), By Application (Military, Civilian), By End User, By Region - Industry Forecast 2025-2032

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

バイオディフェンス市場規模：製品別& CAGR（2025-2032）

バイオディフェンス市場規模：用途別& CAGR（2025-2032）

バイオディフェンス市場規模：エンドユーザー別& CAGR（2025-2032）

バイオディフェンス市場規模：地域別& CAGR（2025-2032）